Business Context and Reporting Period
This Form 8-K Current Report was filed by cbdMD, Inc. on October 25, 2023. The filing addresses a significant corporate governance event regarding a scheduled shareholder meeting.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a corporate event and does not contain financial statement data.
Material Changes
The primary material change reported is the cancellation of a special meeting of shareholders that was originally scheduled for October 26, 2023. Consequently, the Company withdrew the proposals set forth in its Definitive Proxy Statement on Schedule 14A, which was filed on August 11, 2023.
Guidance, Outlook, and Risks
The filing does not contain updated financial guidance, management commentary on future outlook, or specific risk factors beyond the implications of the withdrawn shareholder proposals. The Company attached a press release (Exhibit 99.1) detailing the decision to cancel the meeting.
Investor Verification Checklist
- Verify the specific reasons for canceling the special shareholder meeting by reviewing the attached press release (Exhibit 99.1).
- Confirm the status of the proposals previously outlined in the August 11, 2023, Definitive Proxy Statement on Schedule 14A.
- Check for any subsequent filings regarding the rescheduling of the meeting or the withdrawal of the proposals.
- Review the Company's most recent 10-Q or 10-K for current financial metrics, as this 8-K does not contain them.